Quick answers
- What is Technescan tc 99M mertiatide used for?
- The FDA-approved label (Technescan MAG3, Curium US LLC, January 6, 2026) says: “Technetium Tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (See Pediatric Use. ) It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- What are the side effects of Technescan tc 99M mertiatide?
- The “Adverse Reactions” section of the FDA label (Technescan MAG3, Curium US LLC, January 6, 2026) begins: “The following adverse reactions have been reported: nausea, vomiting, wheezing, dyspnea, itching, rash, tachycardia, hypertension, shaking chills, fever, and seizure.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Technescan tc 99M mertiatide have a boxed warning?
- No. None of the 3 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Technescan tc 99M mertiatide?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Technescan tc 99M mertiatide been recalled?
- FDA enforcement reports list 1 recall of products of this medicine; the newest started September 3, 2025 (Class II). A recall usually concerns specific lots, not every product.
- Who makes Technescan tc 99M mertiatide?
- 3 companies list prescription products of Technescan tc 99M mertiatide in the FDA NDC Directory, including Curium US LLC, Jubilant DraxImage Inc., dba Jubilant Radiopharma and Sun Pharmaceutical Industries, Inc.
What Technescan tc 99M mertiatide is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Technetium Tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (See Pediatric Use. ) It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.
— FDA label: Technescan MAG3, Curium US LLC, effective January 6, 2026. Read the full label on DailyMed →
Label quoted: the one for the most common form (injection, powder, lyophilized, for solution, intravenous), Technescan MAG3, Curium US LLC; it covers 1 product in the FDA NDC Directory. The side effects, interactions, dosage and pregnancy quotes below come from this same label.
The FDA has 3 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 3 FDA labels for this medicine have a boxed warning.
Technescan tc 99M mertiatide side effects
Quoted from the “Adverse Reactions” section of the FDA-approved label. Tell your doctor about any side effect that worries you.
The following adverse reactions have been reported: nausea, vomiting, wheezing, dyspnea, itching, rash, tachycardia, hypertension, shaking chills, fever, and seizure.
— FDA label: Technescan MAG3, Curium US LLC, effective January 6, 2026. Read the full label on DailyMed →
Technescan tc 99M mertiatide dosage
Quoted from the “Dosage and Administration” section of the FDA-approved label. Your own dose is the one your doctor prescribes: do not change it on your own.
The suggested dose range employed in the average adult patient (70 kg) for renal function and imaging studies is 185 MBq (5 mCi) to 370 MBq (10 mCi). In pediatric patients the recommended dose range is 2.6 MBq/kg (70 μCi/kg) to 5.2 MBq/kg (140 μCi/kg) with a minimum dose of 37 MBq (1 mCi). The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration.
Read more of this section
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Aseptic procedures and a shielded syringe should be employed in withdrawing doses for administration to patients. The user should wear waterproof gloves during the administration procedure.
— FDA label: Technescan MAG3, Curium US LLC, effective January 6, 2026. Read the full label on DailyMed →
Technescan tc 99M mertiatide in pregnancy
Quoted from the pregnancy part of the FDA-approved label. Ask your doctor before you take any medicine while pregnant or planning a pregnancy.
Animal reproduction studies have not been conducted with technetium Tc 99m mertiatide. It is also not known whether this drug can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Technetium Tc 99m mertiatide should be given to a pregnant woman only if clearly needed.
— FDA label: Technescan MAG3, Curium US LLC, effective January 6, 2026. Read the full label on DailyMed →
Technescan tc 99M mertiatide and breastfeeding
Quoted from the nursing mothers / lactation part of the FDA-approved label.
Technetium Tc 99m is excreted in human milk during lactation, therefore, formula feedings should be substituted for breast feeding.
— FDA label: Technescan MAG3, Curium US LLC, effective January 6, 2026. Read the full label on DailyMed →
Forms and how it is given
| Dosage forms | Injection, powder, lyophilized, for solution |
|---|---|
| Route | Intravenous |
| Prescription products | 3 in the FDA NDC Directory |
| Brand names | Technescan MAG3, Kit for the Preparation of Technetium TC99M Mertiatide |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Curium US LLC1 product
- Jubilant DraxImage Inc., dba Jubilant Radiopharma1 product
- Sun Pharmaceutical Industries, Inc.1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA019882 TECHNESCAN MAG3 | Curium | June 15, 1990 | 8, latest July 28, 2014 2014: Manufacturing (CMC) · 2001: Manufacturing (CMC) · 1998: Manufacturing (CMC) |
| NDA216820 TECHNETIUM TC 99M MERTIATIDE KIT | Jubilant Draximage | January 30, 2023 | — |
Generic approvals (1)
- ANDA208994Sun Pharm Inds Inc · July 12, 2019
Shortage status
The FDA drug shortage list does not show these products.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
September 3, 2025 · Class II · Ongoing · D-0658-2025
Failed Dissolution Specifications-Out of Specification (OOS) observation for sulphate in Sodium Tartrate Dihydrate used for the production of Mertiatide.
Kit for the Preparation of Technetium Tc 99m Mertiatide, Rx Only, Manufactured by: Sun Pharmaceutical Industries, Inc. Billerica, MA 01821, NDC 45567-0655-1 — SUN PHARMACEUTICAL INDUSTRIES INC
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
| SPL set ID of the quoted label | 0571c18b-1d5e-47bd-bddf-54d74ce1b442 |
|---|---|
| FDA labels (SPL) | 3 |
| FDA applications | NDA019882, NDA216820, 1 ANDA |
| Active ingredients (FDA) | BETIATIDE |
Next steps
- Find a pharmacy near youAsk which price applies to you and whether your product is affected by a recall
- Latest FDA drug recallsAll medicines, newest first
- Technescan MAG3Brand page: products, maker and price
- Curium US LLCMaker or distributor
- Jubilant DraxImage Inc., dba Jubilant RadiopharmaMaker or distributor
- Sun Pharmaceutical Industries, Inc.Maker or distributor
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Technescan MAG3, Curium US LLC, effective January 6, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →